Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04436523 · ClinicalTrials.gov registry record · NA

Blood Flow Restriction After Meniscus Repair

A NA study, sponsored by University of California, San Francisco.

Terminated
Registry status
NA
Development phase
15
Enrollment target

NCT04436523 is a NA study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04436523, a NA study, was terminated before completion, sponsored by University of California, San Francisco.

TERMINATED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate post-operative outcomes after meniscus surgery in participants undergoing blood flow restriction training as a rehabilitative adjunct compared to those with standard rehabilitation.

Interventions

  • OTHER Standard rehabilitation
  • DEVICE Blood flow restriction (Delfi Personalized Tourniquet System)

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2020-10-20
Est. Completion 2023-06-08
Phase NA

What the Registry Record Tells You About NCT04436523

The ClinicalTrials.gov registry entry for NCT04436523 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Standard rehabilitation is the first listed.

NCT04436523 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04436523 about?

NCT04436523 is a clinical study titled "Blood Flow Restriction After Meniscus Repair". The purpose of this study is to evaluate post-operative outcomes after meniscus surgery in participants undergoing blood flow restriction training as a rehabilitative adjunct compared to those with standard rehabilitation.

What is the current status of trial NCT04436523?

This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2020-10-20. Estimated completion is 2023-06-08.

What interventions are being tested in trial NCT04436523?

The interventions under investigation include: Standard rehabilitation (OTHER), Blood flow restriction (Delfi Personalized Tourniquet System) (DEVICE).

Who is sponsoring clinical trial NCT04436523?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.